Krishanveer Forg (513369)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• ROE of 17.76% and ROCE of 20.04% indicate strong capital efficiency
• Piotroski F-Score of 7/9 points to sound financial fundamentals
• Profit growth of 85.95% with PEG of 0.39 suggests attractive earnings momentum
• Sales growth of 11.95% shows the business is expanding
• Dividend yield of 1.88% offers modest shareholder return

Concerns

• Market cap of just ₹107 Cr means limited size, liquidity, and coverage
• P/E of 19.25 and P/B of 2.52 are not deep-value multiples for a small cyclical
• Profit growth far outpacing sales growth may be a low-base or one-off effect
• Debt/equity and promoter holding data are unavailable; the 52-week range also appears inconsistent with the current price

AI Analysis

At ₹93.87, Krishanveer Forg wears a mask that Mr. Market may be mispricing. My first test is always: can the business generate strong returns on capital without excessive leverage? Here, ROE of 17.76% and ROCE of 20.04% are respectable, and a Piotroski score of 7/9 suggests the recent earnings improvement is backed by improving fundamentals, not just accounting cosmetics. The shallow moat worries me. This is a small-cap casting and forging player with a market cap of only ₹107 crore; it operates in a competitive, cyclical industry where pricing power is often weak. Sales grew 11.95%, yet profit jumped 85.95%. That kind of divergence can come from operating leverage, cost controls, or a low base, but it rarely repeats at the same pace. The PEG of 0.39 looks enticing, but only if the growth is durable. The balance sheet item is not available, which is a caution: I cannot judge true financial risk without knowing the debt structure. At P/E 19.25 and P/B 2.52, I am paying a fair amount for a tiny player. The dividend yield of 1.88% is a minor compensation. Benjamin Graham would demand a margin of safety; at current price, I see some, but not enough to ignore the data gaps. I would not rush in. I would want to see the next few quarters confirming that profit growth is translating into cash flows, and that sales momentum is broadening. The 52-week range data seems inconsistent with the traded price, which reminds me to double-check every number before acting. For now, it is a fast grower on my watchlist, not a proven compounding machine.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer